COMMUNIQUÉS West-GlobeNewswire

Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
29/05/2024
Findings from 23andMe research on Parkinson’s disease published in Brain The LRRK2 variant is strongly associated with symptoms of Parkinson’s disease (PD) that are different from non-variant carriers with the disease [...]
Clover Health Announces Counterpart Health, a New SaaS and Tech Enabled Services Solution to Bring the Power of CA Technology to all Medicare Advantage Payors and Providers
29/05/2024
FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) , a physician enablement technology company committed to bringing access to [...]
Merus to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
29/05/2024
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and [...]
Nusano Expands Executive Management to Support Q1 2025 Radioisotope Commercialization
29/05/2024
VALENCIA, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of medical radioisotopes, today announced the addition of three executives to enhance and expand key [...]
GTG Launches Revolutionary geneType Test covering 100% Risk of Breast and Ovarian Cancer
29/05/2024
MELBOURNE, Australia, May 29, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased [...]
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
29/05/2024
PHILADELPHIA, May 29, 2024 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed [...]
Castellum, Inc. Announces Leadership Changes
29/05/2024
VIENNA, Va., May 29, 2024 (GLOBE NEWSWIRE) -- Castellum, Inc. (the “Company” or “Castellum”) (NYSE-American: CTM), a cybersecurity, electronic warfare, and software services company focused on the federal government, [...]
Casey House creates fictitious drug, Stigmavir, to smash HIV stigma within the health care system
29/05/2024
Specialty hospital uses Gloria Gaynor's I will Survive to create a PSA that calls on health care practitioners to deliver equitable care for those living with HIV TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Casey House – [...]
Affimed Receives Fast Track Designation for Combination Therapy of AFM24 with Atezolizumab for EGFR Wild-Type Non-Small Cell Lung Cancer
29/05/2024
Efficacy and safety of AFM24 in combination with atezolizumab, a checkpoint inhibitor, is being evaluated in non-small cell lung cancer patients with EGFR wild-type and EGFR mutant advanced/metastatic cancers in the [...]
Listen in on ALK’s Capital Markets Day on 4 June 2024
29/05/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ) will host a Capital Markets Day on 4 June at 13.00-17.00. We cordially invite investors, analysts, and other interested stakeholders to listen in on our Capital Markets Day 2024, [...]
Curium Extends Irradiation Partnership With NRG I PALLAS in Netherlands for Continuous Supply of Lutetium-177 to Treat 1,000s of Cancer Patients Each Year
29/05/2024
PARIS, May 29, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that it has signed a long-term agreement to extend its current partnership with NRG I PALLAS for new irradiation [...]
Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication
29/05/2024
CellEDIT Service represents a novel workflow leveraging FluidFM-mediated intranuclear nanoinjection of CRISPR/Cas9 components into single cells. Control of the amount and stoichiometry of RNP complexes could boost [...]
Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
29/05/2024
ANV600 combines a non-blocking α PD-1 antibody and an IL-2Rβ/γ selective agonist targeting IL-2 to tumor-specific T cells resulting in proliferation and increase of tumor-killing potential BASEL, Switzerland, May 29, [...]
Burning Rock Reports First Quarter 2024 Financial Results
29/05/2024
GUANGZHOU, China, May 29, 2024 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) [...]
FDA grants Priority Review to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
29/05/2024
Priority Review recognises the best-in-class potential of the inavolisib-based regimen for patients in urgent need of new treatment options 1,2 Additional analyses of INAVO120 will be presented in an oral abstract [...]
Smart for Life Announces Updates on Successful Completion of Restructuring Program
29/05/2024
Program Has Provided Material Loss Reductions and Transformation of the Company’s Balance Sheet; Company Provides Update on Timing for Form 10-Q MIAMI, May 28, 2024 (GLOBE NEWSWIRE) -- Smart for Life, Inc. (Nasdaq: SMFL [...]
1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China
28/05/2024
FREMONT, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Today Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that its 1-laser and 2-laser 6-color TBNK reagent cocktails have received China National Medical Products [...]
Assure Holdings Receives Notification of Delinquency from Nasdaq
28/05/2024
DENVER, May 28, 2024 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “ Company ” or “ Assure ”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“ IONM ”) and remote neurology services, today announced that [...]
Cronos Terminates Sale-Leaseback of Peace Naturals Campus
28/05/2024
TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it has terminated its agreement (the “Sale Agreement”) with Future Farmco Canada [...]

Pages